Global retinoblastoma presentation and analysis by national income level ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ... JAMA oncology 6 (5), 685-695, 2020 | 273 | 2020 |
Novel insights and therapeutic interventions for pediatric osteosarcoma L Kager, G Tamamyan, S Bielack Future Oncology 13 (4), 357-368, 2016 | 232 | 2016 |
Frontline treatment of acute myeloid leukemia in adults G Tamamyan, T Kadia, F Ravandi, G Borthakur, J Cortes, E Jabbour, ... Critical reviews in oncology/hematology 110, 20-34, 2017 | 162 | 2017 |
Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes GN Tamamyan, HM Kantarjian, J Ning, P Jain, K Sasaki, KL McClain, ... Cancer 122 (18), 2857-2866, 2016 | 127 | 2016 |
Chemotherapy induced thrombocytopenia in pediatric oncology G Tamamyan, S Danielyan, MP Lambert Critical reviews in oncology/hematology 99, 299-307, 2016 | 41 | 2016 |
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, AA Abdulrahaman, ... The Lancet global health 10 (8), e1128-e1140, 2022 | 38 | 2022 |
Incidence of retinoblastoma has increased: results from 40 European countries AW Stacey, R Bowman, A Foster, TT Kivelä, FL Munier, N Cassoux, ... Ophthalmology 128 (9), 1369-1371, 2021 | 37 | 2021 |
War in the time of COVID-19: humanitarian catastrophe in Nagorno-Karabakh and Armenia AM Kazaryan, B Edwin, A Darzi, GN Tamamyan, MA Sahakyan, ... The Lancet Global Health 9 (3), e243-e244, 2021 | 37 | 2021 |
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries ID Fabian, AW Stacey, A Foster, TT Kivelä, FL Munier, N Keren-Froim, ... British Journal of Ophthalmology 105 (10), 1435-1443, 2021 | 27 | 2021 |
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents A Attarbaschi, O Abla, L Ronceray, S Bansil, S Bomken, B Burkhardt, ... Blood advances 3 (24), 4291-4297, 2019 | 24 | 2019 |
Hemophagocytic lymphohistiocytosis in adults: An under recognized entity AR Shah, T Muzzafar, R Assi, D Schellingerhout, Z Estrov, G Tamamyan, ... BBA clinical 7, 36-40, 2017 | 22 | 2017 |
Overview of cancer control in Armenia and policy implications K Bedirian, T Aghabekyan, A Mesrobian, S Shekherdimian, D Zohrabyan, ... Frontiers in Oncology 11, 782581, 2022 | 20 | 2022 |
Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female–A case report and literature review S Bardakhchyan, L Kager, S Danielyan, A Avagyan, N Karamyan, ... Italian Journal of Pediatrics 43, 1-7, 2017 | 20 | 2017 |
The clinical impact of time to response in de novo accelerated‐phase chronic myeloid leukemia M Ohanian, HM Kantarjian, M Shoukier, S Dellasala, A Musaelyan, ... American journal of hematology 95 (10), 1127-1134, 2020 | 13 | 2020 |
Cancer disparities in war-torn and post-war regions D Mired, S Johnson, G Tamamyan Nature Reviews Cancer 20 (7), 359-360, 2020 | 11 | 2020 |
Availability of essential medicines for pediatric oncology in Armenia T Simonyan, R Papyan, S Danielyan, L Sargsyan, V Grigoryan, ... Asian Pacific journal of cancer prevention: APJCP 20 (4), 991, 2019 | 10 | 2019 |
Identifying barriers to treatment of childhood rhabdomyosarcoma in resource‐limited settings: A literature review R Papyan, G Tamamyan, S Danielyan, A Tananyan, A Muradyan, R Saab Pediatric Blood & Cancer 66 (7), e27708, 2019 | 9 | 2019 |
Treating adults with Hodgkin lymphoma in the developing world: a hospital-based cohort study from Armenia A Avagyan, S Danielyan, A Voskanyan, L Sargsyan, L Hakobyan, ... Asian Pacific Journal of Cancer Prevention 17 (1), 101-104, 2016 | 9 | 2016 |
Multiple relapses in high‐grade osteosarcoma: When to stop aggressive therapy? G Tamamyan, M Dominkus, S Lang, C Diakos, E Mittheisz, E Horcher, ... Pediatric Blood & Cancer 62 (3), 529-530, 2015 | 9 | 2015 |
Elevated ferritin predicts for inferior survival in patients with acute leukemia and may be an early marker of a underlying systemic pathologic inflammation P Jain, K Casteel, CE Allen, KL McClain, S Wang, S Konoplev, ... Blood 128 (22), 2791, 2016 | 6 | 2016 |